We are live on
!
Find out more
TD Asset Management Portfolio holdings
AUM
$115B
1-Year Est. Return
41.58%
This Fund
S&P 500
This Quarter
Est. Return
-5.54%
1 Year Est. Return
+41.58%
3 Year Est. Return
+119.77%
5 Year Est. Return
+143.7%
10 Year Est. Return
+448.76%
AUM
$79.9B
AUM Growth
-$6.45B
(-7.5%)
Cap. Flow
-$1.92B
Cap. Flow
% of AUM
-2.4%
Top 10 Holdings %
Top 10 Hldgs %
28.59%
Holding
1,534
New
77
Increased
494
Reduced
709
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$128M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$124M |
| 3 |
Broadridge
BR
|
+$105M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$101M |
| 5 |
Motorola Solutions
MSI
|
+$94.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atlassian
TEAM
|
+$332M |
| 2 |
NVIDIA
NVDA
|
+$268M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$190M |
| 4 |
TSMC
TSM
|
+$149M |
| 5 |
Cisco
CSCO
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.97% |
| 2 | Technology | 17.33% |
| 3 | Healthcare | 10.95% |
| 4 | Consumer Discretionary | 9% |
| 5 | Industrials | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Origin Bancorp
OBK
$1.69B
| $2M | ﹤0.01% |
51,160
-3,360
| -6% | -$139K |
|
1002
News Corp Class A
NWSA
$15.3B
| $2M | ﹤0.01% |
132,676
+800
| +0.6% | +$13.4K |
|
1003
Dime Commercial Bancshares
DCOM
$1.82B
| $1.99M | ﹤0.01% |
66,710
-4,274
| -6% | -$136K |
|
1004
Cavco Industries
CVCO
$4.48B
| $1.99M | ﹤0.01% |
9,564
+2,370
| +33% | +$562K |
|
|
HZNP
1005
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.98M | ﹤0.01% |
31,614
+581
| +2% | +$40.6K |
|
1006
PAR Technology
PAR
$721M
| $1.98M | ﹤0.01% |
65,124
-3,680
| -5% | -$137K |
|
|
LSXMK
1007
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $1.98M | ﹤0.01% |
68,272
+620
| +0.9% | +$19.3K |
|
1008
Sonoco
SON
$5.78B
| $1.97M | ﹤0.01% |
34,900
+17,600
| +102% | +$1.08M |
|
|
HIII
1009
DELISTED
Hudson Executive Investment Corp. III Class A Common Stock
HIII
| $1.97M | ﹤0.01% |
200,000
| – | – |
|
|
JUGG
1010
DELISTED
Jaws Juggernaut Acquisition Corporation Class A Ordinary Share
JUGG
| $1.97M | ﹤0.01% |
200,000
| – | – |
|
1011
Immuneering
IMRX
$281M
| $1.94M | ﹤0.01% |
147,661
| – | – |
|
|
NLSN
1012
DELISTED
Nielsen Holdings plc
NLSN
| $1.91M | ﹤0.01% |
68,925
-8,300
| -11% | -$216K |
|
1013
Onto Innovation
ONTO
$14.1B
| $1.91M | ﹤0.01% |
29,282
+13,082
| +81% | +$961K |
|
1014
StepStone Group
STEP
$4.01B
| $1.9M | ﹤0.01% |
76,188
-5,182
| -6% | -$141K |
|
1015
Algoma Steel
ASTL
$448M
| $1.9M | ﹤0.01% |
290,143
+161,351
| +125% | +$1.44M |
|
|
NARI
1016
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $1.89M | ﹤0.01% |
25,539
-36,324
| -59% | -$2.7M |
|
1017
Cytokinetics
CYTK
$10.7B
| $1.89M | ﹤0.01% |
38,543
+8,600
| +29% | +$414K |
|
|
HTBK
1018
DELISTED
Heritage Commerce
HTBK
| $1.88M | ﹤0.01% |
166,344
-4,298
| -3% | -$49.4K |
|
1019
Utz Brands
UTZ
$1.25B
| $1.87M | ﹤0.01% |
122,110
-7,428
| -6% | -$120K |
|
1020
Lucid Motors
LCID
$2.54B
| $1.86M | ﹤0.01% |
13,116
-279
| -2% | -$48.3K |
|
1021
PRA Group
PRAA
$664M
| $1.85M | ﹤0.01% |
55,820
+8,592
| +18% | +$320K |
|
1022
Revolution Medicines
RVMD
$41.4B
| $1.84M | ﹤0.01% |
94,173
+13,876
| +17% | +$305K |
|
1023
Targa Resources
TRGP
$55.5B
| $1.84M | ﹤0.01% |
30,277
+244
| +0.8% | +$16K |
|
1024
EQT Corp
EQT
$32.2B
| $1.84M | ﹤0.01% |
46,452
-2,968
| -6% | -$129K |
|
1025
Teva Pharmaceuticals
TEVA
$40.5B
| $1.83M | ﹤0.01% |
234,666
-7,591
| -3% | -$67.1K |
|
Similar funds
VAM
TD Asset Management's Q3 2022 Portfolio in Review
As of Q3 2022, TD Asset Management held 1,534 positions worth $79.9B, down 7.5% from $86.3B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
TD Asset Management's Q3 2022 filing shows 77 new, 494 increased, 709 reduced and 60 closed positions. Its largest new stake was Eagle Materials: 154,517 shares worth $16.4M. The largest sale was Atlassian, an estimated $332M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.
- TD Asset Management's largest Q3 2022 buy was Eagle Materials: 154,517 shares worth $16.4M.
- TD Asset Management added most to Thermo Fisher Scientific in Q3 2022, an estimated $128M increase.
- TD Asset Management's biggest Q3 2022 reduction was NVIDIA, cutting an estimated $268M.
- TD Asset Management fully exited Atlassian in Q3 2022, selling an estimated $332M.
- TD Asset Management's ten largest holdings make up 29% of its $79.9B portfolio in Q3 2022.
- TD Asset Management opened 77 new positions and closed 60 in Q3 2022.
- TD Asset Management's portfolio value fell 7.5% quarter-over-quarter to $79.9B.
Based on TD Asset Management's 13F filing for Q3 2022, filed 7 Nov 2022.